Cathepsin-D, Adiponectin, TNF-α, IL-6 and hsCRP plasma levels in subjects with diabetic foot and possible correlation with clinical variables: A multicentric study

Foot

Volumn 22, Issue 3, 2012, Pages 194-199

  Ahmad, Jamal ^a   Zubair, Mohammad ^a   Malik, Abida ^a   Siddiqui, Mohammad A ^b   Wangnoo, Subhash K ^b  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

Diabetic foot ulcer; India; Multicentric study; Pre and pro inflammatory cytokines

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CATHEPSIN D; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC FOOT; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETINOPATHY; SMOKING;

ADIPONECTIN; BODY MASS INDEX; C-REACTIVE PROTEIN; CATHEPSIN D; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DIABETIC FOOT; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865579380     PISSN: 09582592     EISSN: 15322963     Source Type: Journal    
DOI: 10.1016/j.foot.2012.03.015     Document Type: Article

References (30)

1. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-228.
2. Zubair M., Malik A., Ahmad J. Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India. The Foot 2011, 21(March (1)):6-14.
3. Boultan A.J. The diabetic foot from art to science. The 18th camilto golgi lecture. Diabetologia 2004, 47:1343-1354.
4. Roghmann M.C., Siddiqui A., Plaisance K., Standiford H. MRSA colonization and risk of MRSA bacteremia in hospitalized patients with chronic ulcer. Journal of Hospital Infection 2001, 47:98-103.
5. Amstrong D.J., Liswood P.J., Todd W.F. Prevalence of mixed infection in the diabetic pedal wound: a retrospective review of 112 infections. Journal of the American Podiatric Medical Association 1995, 85:533-537.
6. Gadepalli R., Dhawan B., Sreenivas V., Kapil A., Ammini A.C., Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006, 29:1727-1732.
7. Jeffcott W.L., Game F., Cavanagh P.R. The role of proinflamattory cytokines in the cause of neuropathic osteoarthropathy (acute charcot foot) in diabetes. Lancet 2005, 366(9502):2058-2061.
8. Beaujoulin M., Baghdiguian S., Glandu-lassis M., Barcham g, Liaudetcoopman E. Overexpression of both catalytically active and inactive Cathepsin D by Cancer cells enhanced apoptosis dependent chemosensitivity. Oncogene 2006, 25:1967-1973.
9. Jerry P., Krzystof S., Edward B. Cathepsin D, inhibitors from potato reverse inhibition of collagen biosynthesis in wounded skin of rats with experimental diabetes. Acta Biochimica Polonica 1999, 38:115-118.
10. Hartemann-Heurtier A., Robert J., Jacqueminet S., Ha Van G., Golmard J.L., Jarlier V., et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabetic Medicine 2004, 21:710-715.
11. Takahashi S., Mao-Jung L.E.E. Collagen metabolism in fibrotic liver. Effects of concanavalin A and aggregated myeloma immunoglobin G. The Biochemical Journal 1987, 241:49-54.
12. Palka J., Soolewski K., Bankowski E. Cathepsin D inhibition for potato reverse inhibition of collagen biosynthesis in wounded skin of rats with experimental diabetes. Acta Biochimica Polonica 1991, 38(1):115-118.
13. Kjellström T., Malmquist J. Insulin effects on collagen and protein production in cultured human skin fibroblasts from diabetic and non-diabetic subjects. Hormone and Metabolic Research 1984, 16:168-171.
14. Almeda-Valdes P., Cuevas-Ramos D., Mehta R., Gomez-Perez F.J., Cruz-Bautista I., Arellano-Campos O., et al. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovascular Diabetology 2010, 9:26. 23.
15. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class ascavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103:1057-1063.
16. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein, adiponectin. Circulation 1999, 100:2473-2476. 11.
17. Pinto A., Tuttolomondo A., Di Raimondo D., Fernandez P., La Placa S., Di Gati M., et al. Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot. Metabolism 2008, 57(5):676-682.
18. Zietz B., Buechler C., Kobuch K., Neumeier M., Schölmerich J. Schäffler Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Experimental and Clinical Endocrinology and Diabetes 2008, 116(9):532-536.
19. Abu el Asrar A.M., Maimone D., Morse P.H., Gregory S., Reder A.T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. American Journal of Ophthalmology 1992, 114(6):731-736.
20. Kojima S., Yamada T., Tamai M. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases. Japanese Journal of Ophthalmology 2001, 45(1):40-45.
21. Schram M.T., Chaturvedi N., Schalkwijk C., et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB prospective complications study. Diabetes Care 2003, 26(7):2165-2173.
22. Sugimoto H., Shikata K., Wada J., Horiuchi S., Makino H. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the over expression of tumournecrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 1999, 42(7):878-886.
23. Balasubramanyam M., Rema M., Premanand C. Biochemical and molecular mechanisms of diabetic retinopathy. Current Science 2002, 83(12):1506-1514.
24. Spyridopoulos I., Brogi E., Kearney M., Sullivan A.B., Cetrulo C., Isner J.M., et al. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: Balance between growth and death signals. Journal of Molecular and Cellular Biology 1997, 29:1321-1330.
25. Boyko E.J., Ahroni J.H., Cohen V., Nelson K.M., Heagerty P.J. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the seattle diabetic foot study. Diabetes Care 2006, 29(6):1202-1207.
26. Tuttle H.A., Davis-Gorman G., Goldman S., Copeland J.G., McDonagh P.F. Cardiovascular proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. Journal of Diabetes and its Complications 2004, 18(6):343-351.
27. Chambers J.C., Eda S., Bassett P., Karim Y., Thompson S.G., Gallimore J.R., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001, 104:145-150.
28. Vikram N.K., Misra A., Pandey R.M., Dwivedi M., Luthra K., Dhingra V., et al. Association between sub clinical inflammation & fasting insulin in urban young adult north Indian males. The Indian Journal of Medical Research 2006, 124:677-682.
29. Anubha M., RubinaT, Sreenivas C., Dwivedi O.P., Bharadwaj M., Tandon N., et al. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. The Journal of Clinical Endocrinology and Metabolism 2009, 94(June (6)):2123-2127.
30. Mohan V., Deepa R., Velmurugan K., Premalatha G. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai urban rural epidemiology study (CURES-6). Diabetic Medicine 2005, 22:863-870.